|
1
|
Attaallah W, Uprak K, Gunal O and Yegen C:
prognostic impact of the metastatic lymph node ratio on survival in
gastric cancer. Indian J Surg Oncol. 7:67–72. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taghizadeh-Kermani A, Yahouiyan SZ,
AliAkbarian M and Toussi Seilanian M: Prognostic significance of
metastatic lymph node ratio in patients with gastric cancer: An
evaluation in north-East of iran. Iran J Cancer Prev. 7:73–79.
2014.PubMed/NCBI
|
|
3
|
Kim SG, Seo HS, Lee HH, Song KY and Park
CH: Comparison of the differences in survival rates between the 7th
and 8th editions of the AJCC tnm staging system for gastric
adenocarcinoma: A single-institution study of 5,507 patients in
Korea. J Gastric Cancer. 17:212–219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Marano L, Polom K, Patriti A, Roviello G,
Falco G, Stracqualursi A, De Luca R, Petrioli R, Martinotti M,
Generali D, et al: Surgical management of advanced gastric cancer:
An evolving issue. Eur J Surg Oncol. 42:18–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
In H, Solsky I, Palis B, Langdon-Embry M,
Ajani J and Sano T: Validation of the 8th edition of the AJCC TNM
staging system for gastric cancer using the national cancer
database. Ann Surg Oncol. 24:3683–3691. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu J, Zheng CH, Cao LL, Li P, Xie JW, Wang
JB, Lin JX, Chen QY, Lin M and Huang CM: The effectiveness of the
8th American Joint Committee on Cancer TNM classification in the
prognosis evaluation of gastric cancer patients: A comparative
study between the 7th and 8th editions. Eur J Surg Oncol.
43:2349–2356. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ji X, Bu ZD, Yan Y, Li ZY, Wu AW, Zhang
LH, Zhang J, Wu XJ, Zong XL, Li SX, et al: The 8th edition of the
American Joint Committee on Cancer tumor-node-metastasis staging
system for gastric cancer is superior to the 7th edition: Results
from a Chinese mono-institutional study of 1663 patients. Gastric
Cancer. 21:643–652. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu J, Zheng CH, Cao LL, Ling SW, Li P, Xie
JW, Wang JB, Lin JX, Chen QY, Lin M, et al: Validation of the
American Joint Commission on Cancer (8th edition) changes for
patients with stage III gastric cancer: Survival analysis of a
large series from a Specialized Eastern Center. Cancer Med.
6:2179–2187. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee YC, Yang PJ, Zhong Y, Clancy TE, Lin
MT and Wang J: Lymph node ratio-based staging system outperforms
the seventh AJCC system for gastric cancer: Validation analysis
with National Taiwan University Hospital Cancer Registry. Am J Clin
Oncol. 40:35–41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Komatsu S, Ichikawa D, Miyamae M, Kosuga
T, Okamoto K, Arita T, Konishi H, Morimura R, Murayama Y, Shiozaki
A, et al: Positive lymph node ratio as an indicator of prognosis
and local tumor clearance in N3 gastric cancer. J Gastrointest
Surg. 20:1565–1571. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu C, Lu P, Lu Y, Xu H, Wang S and Chen
J: Clinical implications of metastatic lymph node ratio in gastric
cancer. BMC Cancer. 7:2002007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kunisaki C, Makino H, Akiyama H, Otsuka Y,
Ono HA, Kosaka T, Takagawa R, Nagahori Y, Takahashi M, Kito F and
Shimada H: Clinical significance of the metastatic lymph-node ratio
in early gastric cancer. J Gastrointest Surg. 12:542–549. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu DZ, Geng QR, Long ZJ, Zhan YQ, Li W,
Zhou ZW, Chen YB, Sun XW, Chen G and Liu Q: Positive lymph node
ratio is an independent prognostic factor in gastric cancer after
d2 resection regardless of the examined number of lymph nodes. Ann
Surg Oncol. 16:319–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deng J, Liang H, Wang D, Sun D, Ding X,
Pan Y and Liu X: Enhancement the prediction of postoperative
survival in gastric cancer by combining the negative lymph node
count with ratio between positive and examined lymph nodes. Ann
Surg Oncol. 17:1043–1051. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee JW, Ali B, Park CH and Song KY:
Different lymph node staging systems in patients with gastric
cancer from Korean: What is the best prognostic assessment tool?
Medicine (Baltimore). 95:e38602016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jian-Hui C, Shi-Rong C, Hui W, Si-le C,
Jian-Bo X, Er-Tao Z, Chuang-Qi C and Yu-Long H: Prognostic value of
three different lymph node staging systems in the survival of
patients with gastric cancer following D2 lymphadenectomy. Tumour
Biol. 37:11105–11113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qiu MZ, Qiu HJ, Wang ZQ, Ren C, Wang DS,
Zhang DS, Luo HY, Li YH and Xu RH: The tumor-log odds of positive
lymph nodes-metastasis staging system, a promising new staging
system for gastric cancer after D2 resection in China. PLoS One.
7:e317362012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu J, Bian YH, Jin X and Cao H: Prognostic
assessment of different metastatic lymph node staging methods for
gastric cancer after D2 resection. World J Gastroenterol.
19:1975–1983. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tóth D, Bíró A, Varga Z, Török M and
Árkosy P: Comparison of different lymph node staging systems in
prognosis of gastric cancer: A bi-institutional study from Hungary.
Chin J Cancer Res. 29:323–332. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Spolverato G, Ejaz A, Kim Y, Squires MH,
Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K,
Acher AW, et al: Prognostic performance of different lymph node
staging systems after curative intent resection for gastric
adenocarcinoma. Ann Surg. 262:991–998. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou R, Zhang J, Sun H, Liao Y and Liao W:
Comparison of three lymph node classifications for survival
prediction in distant metastatic gastric cancer. Int J Surg.
35:165–171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calero A, Escrig-Sos J, Mingol F, Arroyo
A, Martinez-Ramos D, de Juan M, Salvador-Sanchis JL, Garcia-Granero
E, Calpena R and Lacueva FJ: Usefulness of the log odds of positive
lymph nodes to predict and discriminate prognosis in gastric
carcinomas. J Gastrointest Surg. 19:813–820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aurello P, Petrucciani N, Nigri GR, La
Torre M, Magistri P, Tierno S, D'Angelo F and Ramacciato G: Log
odds of positive lymph nodes (LODDS): What are their role in the
prognostic assessment of gastric adenocarcinoma? J Gastrointest
Surg. 18:1254–1260. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeng WJ, Hu WQ, Wang LW, Yan SG, Li JD,
Zhao HL, Peng CW, Yang GF and Li Y: Lymph node ratio is a better
prognosticator than lymph node status for gastric cancer: A
retrospective study of 138 cases. Oncol Lett. 6:1693–1700. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ke B, Song XN, Liu N, Zhang RP, Wang CL
and Liang H: Prognostic value of the lymph node ratio in stage III
gastric cancer patients undergoing radical resection. PLoS One.
9:e964552014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun Z, Xu Y, Li de M, Wang ZN, Zhu GL,
Huang BJ, Li K and Xu HM: Log odds of positive lymph nodes: A novel
prognostic indicator superior to the number-based and the
ratio-based N category for gastric cancer patients with R0
resection. Cancer. 116:2571–2580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W, Xu DZ, Li YF, Guan YX, Sun XW,
Chen YB, Kesari R, Huang CY, Li W, Zhan YQ and Zhou ZW:
Tumor-ratio-metastasis staging system as an alternative to the 7th
edition UICC TNM system in gastric cancer after D2
resection-results of a single-institution study of 1343 Chinese
patients. Ann Oncol. 22:2049–2056. 2011. View Article : Google Scholar : PubMed/NCBI
|
